BGT vs CQT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

36LOW

CQT

CONNEQT FPO [CQT]

36LOW

Score Breakdown

BGT CQT
Technical
48
42
Catalyst
50
52
Sentiment
50
50
Fundamental
44
16
Momentum
52
40
Risk Gate
27
29

Key Metrics

BGT Metric CQT
$6.6MMarket Cap$19.9M
754KAvg Volume (20d)804K
N/AShort InterestN/A
$0.06152-Week High$0.064
$0.01652-Week Low$0.020
+0.0%Daily Change-4.6%
$0.017Entry Price$0.021
-202.2%ROE-830.9%
N/AProfit Margin-296.9%

Active Signals

BGT Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●Lagging the Small Ords index — relative strength of 0.83, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)

CQT Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Lagging the Small Ords index — relative strength of 0.87, underperforming its peers
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.0 quarters)
●Low P/S ratio (3.4x)
●Revenue declining (-8%)

Ask Scout AI to compare BGT and CQT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BGT Full Analysis → CQT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).